Abstract: The present disclosure relates to a blood perfusion device, and more specifically to a blood perfusion device which includes an anti-mtFP antibody to remove mtFP, thereby blocking the binding of mtFP to formyl peptide receptor 1 (FPR1) on the PMN membrane by removing the mtFP, and is capable of suppressing the occurrence of secondary infection in hospital by restoring the chemotaxis of polymorphonuclear leukocytes (PMN). The present disclosure can reduce late death and improve long-term survival by improving the clinical course of sepsis patients recovering after the acute phase, and it is expected to improve long-term survival by suppressing the occurrence of secondary infections in hospital for patients who require long-term hospitalization in the intensive care unit or hospital room, such as severe trauma patients, organ transplant patients and patients surviving after cardiac arrest.

Abstract: An automatic cardiopulmonary resuscitation device includes a movable chest compressor for repeatedly pressing a patient's chest at a preset depth and cycle, a cardiac output measurement unit for measuring a cardiac output of the patient in accordance with the pressurization of the chest compressor and a processor for changing pressing locations by performing control such that the chest compressor moves according to a preset method.

Abstract: An automatic cardiopulmonary resuscitation device and a control method therefor are disclosed. The automatic cardiopulmonary resuscitation device comprises: a movable chest compressor for repeatedly pressing a patient's chest at a preset depth and cycle; a cardiac output measurement unit for measuring a cardiac output of the patient in accordance with the pressurization of the chest compressor; and a processor for changing pressing locations by performing control such that the chest compressor moves according to a preset method, wherein the processor controls the cardiac output measurement unit such that the cardiac output measurement unit measures the patient's cardiac output at each of the changed pressurized locations, selects a pressing location at which the patient's cardiac output becomes the maximum on the basis of the measured cardiac output, and performs control such that the chest compressor moves to the pressing location at which the patient's cardiac output becomes the maximum.

Abstract: A cytokine adsorption sheet comprises a nanofiber web formed by electrospinning a spinning solution prepared by mixing an adsorbent material capable of adsorbing cytokine and an electrospinnable polymer material. Thus, the dissolution of the adsorbent material by blood can be prevented.